Jane Street’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,366
Closed -$39.2K 12743
2025
Q4
$39.2K Sell
11,366
-59,061
-84% -$236K ﹤0.01% 10571
2025
Q3
$360K Sell
70,427
-16,303
-19% -$85.1K ﹤0.01% 8553
2025
Q2
$459K Buy
86,730
+22,986
+36% +$167K ﹤0.01% 7086
2025
Q1
$519K Buy
63,744
+10,789
+20% +$101K ﹤0.01% 6799
2024
Q4
$678K Sell
52,955
-36,440
-41% -$430K ﹤0.01% 6122
2024
Q3
$958K Buy
89,395
+22,032
+33% +$207K ﹤0.01% 5984
2024
Q2
$534K Buy
67,363
+54,378
+419% +$517K ﹤0.01% 6915
2024
Q1
$208K Sell
12,985
-11,556
-47% -$187K ﹤0.01% 8130
2023
Q4
$337K Buy
+24,541
New +$281K ﹤0.01% 7436
2023
Q2
Sell
-140,851
Closed -$1.97M 9424
2023
Q1
$1.97M Buy
+140,851
New +$1.5M ﹤0.01% 3856
2022
Q4
Sell
-30,749
Closed -$162K 9959
2022
Q3
$162K Buy
+30,749
New +$190K ﹤0.01% 8348
2022
Q1
Sell
-18,387
Closed -$220K 10905
2021
Q4
$220K Buy
+18,387
New +$280K ﹤0.01% 8673
2021
Q2
Sell
-20,830
Closed -$413K 10296
2021
Q1
$413K Sell
20,830
-4,425
-18% -$103K ﹤0.01% 7136
2020
Q4
$469K Buy
+25,255
New +$554K ﹤0.01% 5840
2020
Q3
Sell
-14,445
Closed -$441K 7784
2020
Q2
$441K Buy
+14,445
New +$442K ﹤0.01% 5265
2020
Q1
Sell
-2,194
Closed -$100K 5856
2019
Q4
$100K Buy
+2,194
New +$91.2K ﹤0.01% 4855

Other funds holding RCEL

Jane Street's RCEL Position: Q1 2026 in Review

Jane Street sold out of Avita Medical (RCEL) in Q1 2026, closing a stake of 11,366 shares — an estimated $39.2K sold.

Jane Street first reported a position in RCEL in Q4 2019 and held it in 16 quarters. The position peaked at $1.97M in Q1 2023. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • Jane Street reported no remaining Avita Medical position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 11,366 Avita Medical shares in Q1 2026, an estimated $39.2K.
  • Jane Street first reported a position in Avita Medical in Q4 2019 and held it in 16 quarters.
  • Jane Street's Avita Medical position peaked at $1.97M in Q1 2023.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.